AMAnoosha Marium

Anoosha Marium

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anoosha Marium has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cardiac Dysfunction After Arteriovenous Fistula Creation: A Clinical Dilemma in Identifying High-Risk Patients

    by Anoosha Marium, Farhala Baloch, Nadeem Ahmed Siddiqui

    Heart failure is prevalent among patients with end-stage renal disease (ESRD), particularly those receiving maintenance hemodialysis. Arteriovenous fistulas (AVFs) remain the preferred form of long-term vascular access because of their durability and lower risk of infectious and other complications. Creation of an AVF produces important hemodynamic alterations which may impose additional cardiovascular stress in susceptible patients. Although these adaptations are generally well tolerated, patients with pre-existing cardiovascular disease, limited cardiac reserve, or excessive access flow may develop or experience worsening cardiac dysfunction, including high-output heart failure. This short communication discusses selected evidence concerning the cardiovascular consequences of AVF creation, factors associated with increased hemodynamic burden, and practical considerations for identifying, evaluating, and managing patients at increased risk of AVF-associated cardiac dysfunction. An individualized approach incorporating baseline cardiovascular status, access characteristics, clinical findings, and post-AVF hemodynamic assessment is essential to balance adequate dialysis access against cardiovascular tolerance.

  • Open Access

    Cardiovascular Disease in Pregnancy: Challenges, Care and Collaboration in Low- and Middle-income Countries

    by Anoosha Marium, Syed Oun Abbas, Hamna Jaskani, Dur-E Shahwar, Farhala Baloch

    Cardiovascular disease (CVD) in pregnancy is a global healthcare concern. An early diagnosis is crucial to decrease maternal morbidity and mortality. In low- and middle-income countries (LMICs), several factors contribute to the late diagnosis and subsequent treatment of CVD in pregnancy, ranging from cultural and socio-economic barriers at an individual level to nation-based factors such as the availability of health infrastructure and quality of care. This review highlights these challenges in detail and emphasises the need for targeted measures within the women’s and children’s health sectors of LMICs. Focus has been placed on plausible solutions, such as expanding access to specialised cardiovascular screening in antenatal care, improving rural healthcare infrastructure, implementing national maternal CVD registries, and integrating telemedicine to overcome geographic and resource barriers in LMICs.